pfenex.com

Home | Pfenex | Innovative solutions for global health

Financials & Filings. We are a clinical stage development and licensing biotechnology company focused on leveraging our. Pfenex Expression Technology platform to develop and improve protein therapies for unmet patient needs. Learn about Pfenex Expression Technology and our other state of the art production capabilities. Learn about our advanced pipeline of therapeutic equivalents, vaccines, biologics, and biosimilars.

http://www.pfenex.com/

OVERVIEW OF pfenex.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

18

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR PFENEX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 14 reviews

5 star

8

4 star

3

3 star

2

2 star

0

1 star

1

Hey there! Start your review of pfenex.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.5 seconds

FAVICON PREVIEW

16x16

CONTACTS AT PFENEX.COM

Pfenex Inc.

Bertrand Liang

10790 R●●●●●●● Street

San●●●ego , California, 92121

United States

1.85●●●●4400

1.85●●●●4339

hw●@pfenex.com

View this contact

Pfenex Inc.

Cassidy Brady

10790 R●●●●●●●Streeet

San●●●ego , California, 92121

United States

1.85●●●●4312

1.85●●●●4339

cb●●●●@pfenex.com

View this contact

Pfenex Inc.

Holly Aldrich

10790 R●●●●●●● Street

San●●●ego , California, 92121

United States

1.85●●●●4462

1.85●●●●4339

ho●●●@pfenex.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2005 March 08
UPDATED: 2013 March 11
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

19

YEARS
2

MONTHS
14

DAYS

NAME SERVERS

1: ns.rackspace.com
2: ns2.rackspace.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

18

SSL

EXTERNAL LINKS

97

SITE IP

104.196.158.64

LOAD TIME

0.469 sec

SCORE

6.2

PAGE TITLE

Home | Pfenex | Innovative solutions for global health | pfenex.com Reviews

<META> DESCRIPTION

Financials & Filings. We are a clinical stage development and licensing biotechnology company focused on leveraging our. Pfenex Expression Technology platform to develop and improve protein therapies for unmet patient needs. Learn about Pfenex Expression Technology and our other state of the art production capabilities. Learn about our advanced pipeline of therapeutic equivalents, vaccines, biologics, and biosimilars.

<META> KEYWORDS

1 about us

2 team

3 technology

4 partners

5 investors

6 corporate governance

7 news releases

8 annual reports

9 stock information

10 events

CONTENT

Page content here

KEYWORDS ON PAGE

about us,team,technology,partners,investors,corporate governance,news releases,annual reports,stock information,events,investor faqs,investor alerts,careers,welcome to pfenex,platform,portfolio,partnerships,twitter,linkedin,facebook

SERVER

nginx

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home | Pfenex | Innovative solutions for global health | pfenex.com Reviews

https://pfenex.com

Financials & Filings. We are a clinical stage development and licensing biotechnology company focused on leveraging our. Pfenex Expression Technology platform to develop and improve protein therapies for unmet patient needs. Learn about Pfenex Expression Technology and our other state of the art production capabilities. Learn about our advanced pipeline of therapeutic equivalents, vaccines, biologics, and biosimilars.

INTERNAL PAGES

pfenex.com

1

Board of Directors – Pfenex

http://www.pfenex.com/about-us/board-of-directors

Financials & Filings. William R. Rohn. Robin D. Campbell. Bertrand C. Liang. MD, Ph.D., M.B.A. Hematology-Oncology Clinics of North America, Neuro-oncology. Published by Harcourt (now Elsevier) and is the author of two management books, including. Pragmatic MBA for the Scientific and Technical Executive. Managing and Leading for Science Professionals (What I wished I’d known when moving up the Management Ladder). Both published by Elsevier (Academic Press). Phillip M. Schneider. Dr Fenton retired after a...

2

Product Pipeline – Pfenex

http://www.pfenex.com/about-us/product-pipeline

Financials & Filings. Pfenex is a leading-edge biologics company driven by the desire to provide access to safe, effective, affordable products to market. We have the highest-quality protein production and bioanalytic technology platform approach that allows us to create biosimilars in a highly efficient manner from concept to commercialization. See our complete product pipeline below. BRANDED REFERENCE DRUGS (2015). Biologic Lucentis marketed by Hoffmann-La Roche and Novartis AG. Biologic Cimzia markete...

3

Site Map – Pfenex

http://www.pfenex.com/site-map

Financials & Filings. The State of the Biosimilars Industry. Statement on Introduction of CREATES Act to Support Access to Reference Product. Pfenex applauds Senators Patrick Leahy (D-VT), Chuck Grassley (R-IA), Amy Klobuchar (D-MN), and Mike Lee (R-UT) for their efforts introducing the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES Act). The Act supports access to reference product for biosimilar development, thereby expediting patient access to valuable medicines. Biosim...

4

Newsroom – Pfenex

http://www.pfenex.com/news-room

Financials & Filings. The State of the Biosimilars Industry. Will the approval of Inflectra be a biosimilar adoption tipping point? A Perspective on the Medicare Part B Drug Experiment. Pfenex Chief Business Officer Patrick Lucy to Present Corporate Overview at BIO2016. The Biosimilars Council: Why Trade Organizations Are Key for Biosimilars. Pfenex Chief Medical Officer Hubert Chen to Share Clinical Expertise at Biosimilars & Biobetters Congress. Pfenex CEO and Biosimilars Council Chair Dr. Bert Lia...

5

Position – Pfenex

http://www.pfenex.com/our-position-2

Financials & Filings. Pfenex is uniquely situated to deliver a robust pipeline of biosimilars and vaccines to patients globally. We are committed to working with regulatory agencies, legislators and our partners to create and foster a supportive regulatory environment that ensures patient access to needed therapeutics and vaccines. Including CVS Health, Express Scripts, Kaiser Permanente, Pharmaceutical Care Management Association, and Rite Aid as well as the Federal Trade Commission (FTC). Pfenex Statem...

UPGRADE TO PREMIUM TO VIEW 13 MORE

TOTAL PAGES IN THIS WEBSITE

18

LINKS TO THIS WEBSITE

pfenex.investorroom.com

Welcome

http://pfenex.investorroom.com/welcome

Pfenex is a clinical-stage biotechnology company developing and commercializing high value and difficult to manufacture proteins. Our initial focus is on biosimilar therapeutics and our lead product is PF582, a biosimilar to Lucentis (ranibizumab). Our patented protein production platform, Pfenex Expression Technology. Pfenex is leveraging its technology platform for its own product pipeline. And for scientists seeking reagents for research use. Oct 26, 2016. Oct 19, 2016. Oct 3, 2016. Oct 26, 2016.

pfenex.investorroom.com

Pfenex Inc. - Investors - News Releases

http://pfenex.investorroom.com/news-releases

These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Get News Alerts by Email. Oct 26, 2016. Pfenex To Report Third Quarter 2016 Results and Provide Business Update on Wednesday, November 9, 2016. Oct 19, 2016. Pfenex Inc. Announces Formation of Scientific Advisory Board. Oct 3, 2016. Aug 8, 2016. Pfenex Inc. (NYSE MKT: PFNX), a clinical-stag...

pfenex.investorroom.com

Financial Reporting

http://pfenex.investorroom.com/stock-information

809 - $8.56. 579 - $17.33. Quote data delayed by at least 15 minutes.

biomay.com

Biomay: References

http://www.biomay.com/gmp-contract-manufacturing/references

Peptide Carrier Fusion Vaccines. Analytical Capacities and Quality Control. Clients and Partners for Manufacturing Projects:. Boehringer Ingelheim RCV (AT/DE). Christian Doppler Laboratory for Allergy Research (AT). Christian Doppler Laboratory for Immunomodulation (AT). FAST (EU FP7 project 201871). Fresenius Medical Care (AT/DE). Labor Dr. Merk and Kollegen (DE). Medical University of Vienna (AT). POC Clinical Research (JP). Scil Proteins Production (DE). SynCo Bio Partners (NL).

caliberadvisors.com

Recent Experience | Caliber Advisors, Inc.

http://caliberadvisors.com/category/experience

Caliber Advisors, Inc. Expert Valuation and Economic Consultation. Tax Planning & Compliance. You are here: Home. Purchase Price Allocation for Alliant Insurance Services. July 25, 2016. By Ken B. Nunes, CFA. One of the nation’s leading distributors of diversified insurance products and services, acquired a specialty aviation insurance brokerage in Washington. Caliber Advisors provided Alliant a purchase price allocation for the acquired intangible assets in accordance with FASB ASC 805. July 24, 2016.

rdlogic.com

News

http://www.rdlogic.com/news.html

News Across our Business. Engaging Science and Business. Contact us @ (650) 356-9207. Biospace features R&D Logic in spotlight article. R&D Logic's R&D Time is the software of choice for Intellia Therapeutics for project time collection and FTE reporting. Located in Cambridge, MA, Intellia Therapeutics. R&D Logic's life science focused software suite has been selected by Karyopharm Therapeutics, Inc. for planning, project costing, time collection and reporting. Located in Cambridge, MA, Spero Therapeutic...

pfenex.investorroom.com

Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 - Jul 29, 2015

http://pfenex.investorroom.com/2015-07-29-Pfenex-To-Report-Second-Quarter-2015-Results-and-Provide-Business-Update-on-Thursday-August-13-2015

Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015. Wednesday, July 29, 2015 (8:30am). July 29, 2015. Pfenex Inc. (NYSE MKT: PFNX) announced today that its second quarter 2015 financial results will be released on Thursday, August 13, 2015. Before the open of market. At 8:30 am Eastern Time. Pfenex has used, and intends to continue to use, its Investor Relations website ( http:/ pfenex.investorroom.com. Pfenex Inc. is a clinical-stage biotechnology c...

pfenex.investorroom.com

Pfenex Reports Second Quarter 2015 Results and Provides Business Update - Aug 13, 2015

http://pfenex.investorroom.com/2015-08-13-Pfenex-Reports-Second-Quarter-2015-Results-and-Provides-Business-Update

Pfenex Reports Second Quarter 2015 Results and Provides Business Update. Thursday, August 13, 2015 (7:45am). Aug 13, 2015. Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value and difficult to manufacture proteins, today reported financial results for the second quarter ended June 30, 2015. And provided a business update. Pfenex initiated a Phase 1 trial of PF530, a biosimilar candidate to Betaseron, in the first ...

pfenex.investorroom.com

Pfenex Inc. - Investors - Corporate Governance

http://pfenex.investorroom.com/corporate-governance

Corporate Governance involves the processes and procedures used to manage the business affairs of a company and includes the structure and balance of power between the management and board. View PDF of Corporate Governance Principles. View PDF of Audit Committee Charter. View PDF of Compensation Committee Charter. Corporate Governance and Nominating Committee Charter. View PDF of Corporate Governance and Nominating Committee Charter. Code of Ethics and Conduct. View PDF of Code of Ethics and Conduct.

UPGRADE TO PREMIUM TO VIEW 88 MORE

TOTAL LINKS TO THIS WEBSITE

97

SOCIAL ENGAGEMENT

pages/Pfenex-Inc/105908276167776

pfenex

OTHER SITES

pfenergy.com.au

Pathfinder Energy – Pathfinder Energy

Welcome to Pathfinder Energy Pty Ltd. Pathfinder Energy is a private company established to build a portfolio of oil and gas resources, both conventional and unconventional, primarily in Australia. We have a core of experienced, high quality staff which we supplement with selected contractors to identify, acquire and mature exploration and M & A opportunities. Our focus is currently twofold:. Identify and Secure development and production assets in Australia and South East Asia. Pathfinder Energy Pty Ltd.

pfenergy.es

PLAST & FOAM ENERGY

P and F ENERGY. P and F ENERGY es una empresa pionera en España, en el mercado de la Geotermia. Diseñado por SSII.

pfenergy.it

Giacca Spidi Offerta Spedizione E Reso Gratuiti - Shift Italia Negozi Spedizione Gratuita In 24 Ore - Reso Sempre Gratuito

Moto MX / Enduro. Moto MX / Enduro. Le novità di aprile. Spidi combat evo ii h2out jacket giacche urban nero abbigliamento uomo,spidi. Spidi dogma jacket giacche urban nero abbigliamento uomo,spidi jeans. Spidi combat field h2out jacket giacche urban verde abbigliamento uomo,Spidi. Spidi combat field h2out jacket giacche urban blu abbigliamento uomo,spidi. Spidi 4way h2out giacche urban grigio abbigliamento uomo,pantaloni spidi on. Spidi combat evo ii h2out jacket giacche urban verde nero abbigliamento.

pfenergycenter.blogspot.com

Re: Energy

Wednesday, August 5, 2015. The final Clean Power Plan is here. On Monday, August 3, 2015, the Environmental Protection Agency (EPA) announced the final Clean Power Plan. The rule that will help limit carbon pollution from fossil fuel power plants. What does it mean for Pennsylvania? In Pennsylvania, those targets are:. Each affected facility meets a rate-based standard. 1,305 lbs/MWh for coal, gas (steam turbine), or other fossil fuel. 771 lbs/MWh for natural gas combined cycle (NGCC). For example, DEP k...

pfenerji.com

PF ENERJİ,FUATYEŞİLYURT

PF ENERJİ İNŞAAT SEKTÖRÜNDEKİ ELEKTRİK TAAHHÜT İŞLERİNİN,PROJE AŞAMASINDAN SON AŞAMASINA KADAR ENERJİ İLE İLGİLİ OLAN BÜTÜN SÜREÇLERİNİ,. DÜZENLİ,TEKNİK ŞARTNAMELERE VE YÖNETMELİKLERE UYGUN OLARAK HİZMET KALİTESİNDEN VE MALZEME KALİTESİNDEN ASLA ÖDÜN VERMEDEN İŞ GÜVENLİĞİNİ ÖN PLANDA TUTARAK VE YILLARDIR BU SEKTÖRDE BİR ÇOK PROJEYE ATTIĞI İMZALARDAN KENDİNE TECRÜBE EDİNEREK. YENİ,DİNAMİK,GÜÇLÜ,VE HERŞEYİN MÜKEMMEL OLMASI İÇİN PF ENERJİ 2012 YILINDA KURULMUŞTUR. 21° 10°.

pfenex.com

Home | Pfenex | Innovative solutions for global health

Financials & Filings. We are a clinical stage development and licensing biotechnology company focused on leveraging our. Pfenex Expression Technology platform to develop and improve protein therapies for unmet patient needs. Learn about Pfenex Expression Technology and our other state of the art production capabilities. Learn about our advanced pipeline of therapeutic equivalents, vaccines, biologics, and biosimilars.

pfenex.investorroom.com

Welcome

Pfenex is a clinical-stage biotechnology company developing and commercializing high value and difficult to manufacture proteins. Our initial focus is on biosimilar therapeutics and our lead product is PF582, a biosimilar to Lucentis (ranibizumab). Our patented protein production platform, Pfenex Expression Technology. Pfenex is leveraging its technology platform for its own product pipeline. And for scientists seeking reagents for research use. Aug 17, 2015. Aug 13, 2015. Jul 29, 2015. Aug 17, 2015.

pfenex.staging.wpengine.com

Pfenex – Innovative solutions for global health through biosimilars.

Financials & Filings. We are an innovative, leading-edge company focused on bringing biosimilars to market. Learn more about our approach to biosimilars. Our analytical approach to biosimilars allows us to provide patients access to safe, effective, and affordable products. Learn how this supports our robust product pipeline. Our innovative technology and ability to rapidly create a stockpile of essential vaccines has positioned us as a primary partner with the US Government. Pfenex supports the issuance...

pfenfam.com

www.pfenfam.com

Notice: This domain name expired on 07/13/15 and is pending renewal or deletion. This domain registration expired on 07/13/2015. Do you own this domain? Use of this Site is subject to express Terms of Use. By using this Site, you signify that you agree to be bound by these Terms of Use. Which were last revised on.

pfeng.biz

Doména je registrována na serverech Web4U s.r.o.

Doména je registrována na serverech Web4U s.r.o. Tato doména byla zaregistrována na serverech společnosti Web4U s.r.o., vlastník domény zde zatím nezobrazil žádný obsah. Web4U s.r.o., vše pro vaši internetovou prezentaci.

pfeng.cc

p.feng

My name is Peiying Feng. I also go by Cathy sometimes. I'm an artist and designer who loves creating work that merges different mediums and disciplines. I also love challenges and am always willing to try something new. Some of the work I do includes web design, graphic design, game design, interactive installations, data visualizations and more. In my spare time, I enjoy reading, paintballing and being a unicorn. Interested in working together? Try The World Canada.